Akt-3 Kit

(1 Kit in Strip)
Kit
(1 Strip)
Rs. 8.96 / Kit
Rs.8.96

SALT INFORMATION

Ethambutol(800mg)

INDICATORS

Pregnancy:C Lactation:L3 Lab:NA Food:NA

TYPICAL USAGE

Acute leukemia, non-tuberculous mycobacterial infection, tuberculosis.

SIDE EFFECTS

Vision impairment, stevens-Johnson syndrome, skin inflammation, redness of the skin, itching and joint pain, loss of appetite, nausea, vomiting, stomach upset and abdominal pain, fever, uneasiness, headache, dizziness, mental confusion, decrease in white blood cells and platelets.

DRUG INTERACTION

Ethambutol is known to interact with other drugs like aluminium hydroxide and oxide, bromazepam. These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

MECHANISM OF ACTION

Ethambutol inhibits arabinosyl transferases which is involved in cell wall biosynthesis. By inhibiting this enzyme, the bacterial cell wall complex production is inhibited. This leads to an increase in cell wall permeability.

Isoniazid 1 (Captabs)(300mg)

INDICATORS

Pregnancy:C Lactation:L4 Lab:NA Food:NA

TYPICAL USAGE

Acute leukemia, Mycobacterial infection, Prophylaxis of TB, Tuberculosis, Vestibular disorders.

SIDE EFFECTS

Nausea, Vomiting, Tachycardia, Convulsions, Coma, Seizures, Urinary retention, Dizziness, Hyperreflexia, Slurred speech.

DRUG INTERACTION

Your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with your doctor or pharmacist first.

MECHANISM OF ACTION

Isoniazid is a prodrug and must be activated by bacterial catalase. Specficially, activation is associated with reduction of the mycobacterial ferric KatG catalase-peroxidase by hydrazine and reaction with oxygen to form an oxyferrous enzyme complex. Once activated, isoniazid inhibits the synthesis of mycoloic acids, an essential component of the bacterial cell wall. At therapeutic levels isoniazid is bacteriocidal against actively growing intracellular and extracellular Mycobacterium tuberculosis organisms. Specifically isoniazid inhibits InhA, the enoyl reductase from Mycobacterium tuberculosis, by forming a covalent adduct with the NAD cofactor. It is the INH-NAD adduct that acts as a slow, tight-binding competitive inhibitor of InhA.

Rifampicin(450mg)

INDICATORS

Pregnancy:D Lactation:L4 Lab:NA Food:NA

TYPICAL USAGE

Epilepsy (monotherapy), Iron-deficiency anaemia with chronic renal failure, Leprosy, Meningitis, Meningitis prophylaxis, Mycobacterial infection, Paget's disease of bone, Tuberculosis, Urinary tract infection

SIDE EFFECTS

Nausea, Vomiting, Anorexia, Abdominal discomfort, Orange coloration of secretions.

DRUG INTERACTION

Epilepsy (monotherapy), Iron-deficiency anaemia with chronic renal failure, Leprosy, Meningitis, Meningitis prophylaxis, Mycobacterial infection, Paget's disease of bone, Tuberculosis, Urinary tract infection

MECHANISM OF ACTION

Rifampicin acts via the inhibition of DNA-dependent RNA polymerase, leading to a suppression of RNA synthesis and cell death.

SUBSTITUTES

    No substitutes found